ebo07,nickotime; it has always been my possition that DnaPrint WILL succeed, having been 1st on the block w/ a predictive Genomics Test that defines percentage of Ancestry. This threshold determinant "could" be, perhaps is, the cornerstone of our approach to drug response. It is this seperation of metabolic response that defines the difference in approaches being heralded today. It is all good to say that a particular gene sequence, or lack of these, that regulates reaction to a drug, but then to identify those that inherently have these formations is the crux. Perhaps my concept here is much too simplistic to be considered valid, but as I see it, it is the rendereing down of the vast population structure that I see the value here. All this to say that essentially I can't substantiate my belief thru essoteric principles, but I've hung my hat on what I understand, like most others.
When I first invested in DnaPrint I did think that we had the fast track to acceptance and a "moon ride". These past few years have dissapointing, to say the least, and I place the onus on those that are opposed to redifining the accepted process in the drug industry. There is not a shred of doubt in my mind that there has been a concerted effort to derail, forstall, or bankrupt DnaPrint Genomics by those in the business community. You may notice that I have never indicated that the Scientific Community has rejected what our founder, Dr. Tony Frudakis, has prognosticated concerning his developing work. On the other hand, there has been a palethera of bashers willing to indicate that DnaPrint is inconsequential in it's possition and after 6 years I can only say that there has been one poster who even comes close to defining why they think DnaPrint is a "dead duck", so to speak, and that is frog; all the rest rely on the s/p for validation of their opinion, which I have stated previously has been manipulated to the max.
As Chrisbaskett would say, "but, hey...." My opinion and the only one that counts for me.
Peace, Blessings & Boat Drinks, Easy
